Low-dose Norfloxacin-treated leptospires induce less IL-1β release in J774A.1 cells following discrepant leptospiral gene expression
Low-dose Norfloxacin-treated leptospires induce less IL-1β release in J774A.1 cells following discrepant leptospiral gene expression
复制标题
DOI:
10.1016/j.micpath.2018.03.032
复制
发表时间:
2018-06-01
影响因子:
3.8
通讯作者:
Tu, Changchun
中科院分区:
文献类型:
--
作者:
Cao, Yongguo;Xie, Xufeng;Tu, Changchun
Currently, accumulating evidence is challenging subtherapeutic therapy. Low-dose Norfloxacin (Nor) has been reported to suppress the immune response and worsen leptospirosis. In this study, we investigated the influence of low-dose Nor (0.03 mu g/ml, 0.06 mu g/ml, 0.125 mu g/ml) on leptospiral gene expression and analyzed the immunomodulatory effects of low-dose Nor-treated leptospires in J774A.1 cells. To study the expression profiles of low-dose Nor-treated leptospires, we chose LipL71/LipL21 as reference genes determined by the geNorm applet in this experiment. The results showed that low-dose Nor up-regulated the expression of FlaB and inhibited the expression of 16S rRNA, LipL32, LipL41, Loa22, KdpA, and KdpB compared with the untreated leptospires. These results indicated that low-dose Nor could regulate leptospiral gene expression. Using RT-PCR, the gene expression of IL-1 beta and TNF-alpha in J774A.1 cells was detected. Nor-treated leptospires induced higher expression levels of both IL-1 beta and TNF-alpha. However, when analyzed by ELISA, the release of mature IL-1 beta was reduced compared with that observed in cells induced with no Nor-treated leptospires, although the TNF-alpha protein level showed no significant change. Our study indicated that the gene expression of leptospires could be modulated by low-dose Nor, which induced less IL-1 beta release in J774A.1 cells.